(Q33793308)

29 July 2017

1 reference

title

Molecular pathogenesis of lung cancer (English)

1 reference

29 July 2017

1 reference

Fong KM

1

1 reference

29 July 2017

Sekido Y

series ordinal

2

1 reference

29 July 2017

Minna JD

series ordinal

3

1 reference

29 July 2017

language of work or name

English

0 references

publication date

1 December 1999

1 reference

The Journal of Thoracic and Cardiovascular Surgery

29 July 2017

published in

1 reference

29 July 2017

volume

118

1 reference

29 July 2017

issue

6

1 reference

29 July 2017

page(s)

1136-1152

1 reference

Genetic instabilities in human cancers

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2899%2970121-2

Identification of novel regions of altered DNA copy number in small cell lung tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2899%2970121-2

Reduced survival in patients with stage-I non-small-cell lung cancer associated with DNA-replication errors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2899%2970121-2

Microsatellite instability in primary and metastatic lung carcinomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2899%2970121-2

Mutations in OGG1, a gene involved in the repair of oxidative DNA damage, are found in human lung and kidney tumours

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2899%2970121-2

Bombesin-like peptides and airway repair: a recapitulation of lung development?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2899%2970121-2

Bombesin-like peptides can function as autocrine growth factors in human small-cell lung cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2899%2970121-2

Reduction in receptors for bombesin and epidermal growth factor in xenografts of human small-cell lung cancer after treatment with bombesin antagonist RC-3095.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2899%2970121-2

Antitumor activity of a monoclonal antibody directed against gastrin-releasing peptide in patients with small cell lung cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2899%2970121-2

Expression and activation of erbB-2 and epidermal growth factor receptor in lung adenocarcinomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2899%2970121-2

Inhibition of human lung cancer cell line growth by an anti-p185HER2 antibody.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2899%2970121-2

C-erbB-2 expression and codon 12 K-ras mutations both predict shortened survival for patients with pulmonary adenocarcinomas.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2899%2970121-2

Lack of prognostic significance of epidermal growth factor receptor and the oncoprotein p185HER-2 in patients with systemically untreated non-small-cell lung cancer: an immunohistochemical study on cryosections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2899%2970121-2

Immunoreactivity for hepatocyte growth factor/scatter factor and its receptor, met, in human lung carcinomas and malignant mesotheliomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2899%2970121-2

Overexpression and activation of hepatocyte growth factor/scatter factor in human non-small-cell lung carcinomas.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2899%2970121-2

Insulin-like growth factor expression in human cancer cell lines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2899%2970121-2

Malignant epithelial cells in primary human lung carcinomas coexpress in vivo platelet-derived growth factor (PDGF) and PDGF receptor mRNAs and their protein products

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2899%2970121-2

Opioid and nicotine receptors affect growth regulation of human lung cancer cell lines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2899%2970121-2

The pattern of K-ras mutation in pulmonary adenocarcinoma defines a new pathway of tumour development in the human lung

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2899%2970121-2

High K-ras mutation rates in goblet-cell-type adenocarcinomas of the lungs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2899%2970121-2

Relationship between K-ras oncogene activation and smoking in adenocarcinoma of the human lung.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2899%2970121-2

K-ras oncogene activation as a prognostic marker in adenocarcinoma of the lung

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2899%2970121-2

Prognostic significance of K-ras codon 12 mutations in patients with resected stage I and II non-small-cell lung cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2899%2970121-2

Correlation of intrinsic chemoresistance of non-small-cell lung cancer cell lines with HER-2/neu gene expression but not with ras gene mutations.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2899%2970121-2

Mutational activation of the K-ras oncogene and the effect of chemotherapy in advanced adenocarcinoma of the lung: a prospective study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2899%2970121-2

L-myc, a new myc-related gene amplified and expressed in human small cell lung cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2899%2970121-2

p53: a frequent target for genetic abnormalities in lung cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2899%2970121-2

Molecular epidemiology of human cancer risk: gene-environment interactions and p53 mutation spectrum in human lung cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2899%2970121-2

Preferential formation of benzo[a]pyrene adducts at lung cancer mutational hotspots in P53.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2899%2970121-2

Prognostic significance of abnormal p53 accumulation in primary, resected non-small-cell lung cancers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2899%2970121-2

Non-small cell lung cancer: clinical value of new biological predictors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2899%2970121-2

The TP53 genotype but not immunohistochemical result is predictive of response to cisplatin-based neoadjuvant therapy in stage III non-small cell lung cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2899%2970121-2

p53 mutations predict non-small cell lung carcinoma response to radiotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2899%2970121-2

Retrovirus-mediated wild-type p53 gene transfer to tumors of patients with lung cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2899%2970121-2

Effective treatment of early endobronchial cancer with regional administration of liposome-p53 complexes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2899%2970121-2

Serum p53 antibodies as early markers of lung cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2899%2970121-2

Serum Anti-p53 Antibodies and Prognosis of Patients With Small-Cell Lung Cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2899%2970121-2

Clinical implications of p53 autoantibodies in the sera of patients with non-small-cell lung cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2899%2970121-2

TP53 gene mutations in plasma DNA of cancer patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2899%2970121-2

Cloning and functional analysis of human p51, which structurally and functionally resembles p53

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2899%2970121-2

Mutational analysis of p73 and p53 in human cancer cell lines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2899%2970121-2

p21waf1/cip1mda-6 expression in non-small-cell lung cancer: relationship to survival.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2899%2970121-2

MDM2 gene amplification and expression in non-small-cell lung cancer: immunohistochemical expression of its protein is a favourable prognostic marker in patients without p53 protein accumulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2899%2970121-2

Abnormalities in structure and expression of the human retinoblastoma gene in SCLC.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2899%2970121-2

Altered retinoblastoma protein expression and prognosis in early-stage non-small-cell lung carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2899%2970121-2

Non-ocular cancer in relatives of retinoblastoma patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2899%2970121-2

The role of pRb2/p130 protein in diagnosing lung carcinoma on fine needle aspiration biopsies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2899%2970121-2

Prognostic significance of CCND1 (cyclin D1) overexpression in primary resected non-small-cell lung cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2899%2970121-2

Prognostic role of cyclin D1 in lung cancer. Relationship to proliferating cell nuclear antigen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2899%2970121-2

Intragenic mutations of the p16(INK4), p15(INK4B) and p18 genes in primary non-small-cell lung cancers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2899%2970121-2

Alterations of P16 (MTS1) in node-positive non-small cell lung carcinomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2899%2970121-2

5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2899%2970121-2

Mutations and altered expression of p16INK4 in human cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2899%2970121-2

Differential inactivation of CDKN2 and Rb protein in non-small-cell and small-cell lung cancer cell lines.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2899%2970121-2

Prognostic value of the immunohistochemical detection of p16INK4 expression in nonsmall cell lung carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2899%2970121-2

Deletion mapping of the short arm of chromosome 8 in non‐small cell lung carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2899%2970121-2

Deletion mapping of chromosome 2 in human lung carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2899%2970121-2

Delineation of the centromeric and telomeric chromosome segment 11p15.5 lung cancer suppressor regions LOH11A and LOH11B.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2899%2970121-2

Cloning and tissue expression of cDNAs from chromosome 5q21-22 which is frequently deleted in advanced lung cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2899%2970121-2

Allelotyping demonstrates common and distinct patterns of chromosomal loss in human lung cancer types

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2899%2970121-2

Fine deletion mapping of chromosome 8p in non-small-cell lung carcinoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2899%2970121-2

The FHIT gene 3p14.2 is abnormal in lung cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2899%2970121-2

Abnormal FHIT transcripts found in both lung cancer and normal lung tissue

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2899%2970121-2

Replacement of Fhit in cancer cells suppresses tumorigenicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2899%2970121-2

Protein expression and functional analysis of the FHIT gene in human tumor cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2899%2970121-2

PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2899%2970121-2

Mutation analysis of the PTEN/MMAC1 gene in lung cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2899%2970121-2

Refined mapping of two regions of loss of heterozygosity on chromosome band 11q23 in lung cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2899%2970121-2

Alterations of the PPP2R1B gene in human lung and colon cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2899%2970121-2

bcl-2 protein in non-small-cell lung carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2899%2970121-2

bcl-2 oncoprotein in surgically resected non-small cell lung cancer: possibly favorable prognostic factor in association with low incidence of distant metastasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2899%2970121-2

Prognostic value of the expression of p53, bcl-2, and bax oncoproteins, and neovascularization in patients with radically resected non-small-cell lung cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2899%2970121-2

Expression of bcl-2--protein in small cell lung cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2899%2970121-2

Bcl-2 protein: a prognostic factor inversely correlated to p53 in non-small-cell lung cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2899%2970121-2

Absence of prognostic significance of bcl-2 immunopositivity in non-small cell lung cancer: analysis of 427 cases.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2899%2970121-2

Lack of cell surface Fas/APO-1 expression in pulmonary adenocarcinomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2899%2970121-2

Telomerase Activity in Small-Cell and Non-Small-Cell Lung Cancers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2899%2970121-2

High telomerase activity in primary lung cancers: association with increased cell proliferation rates and advanced pathologic stage.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2899%2970121-2

Aberrant methylation of p16(INK4a) is an early event in lung cancer and a potential biomarker for early diagnosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2899%2970121-2

Distinct hypermethylation patterns occur at altered chromosome loci in human lung and colon cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2899%2970121-2

Identification of CpG islands hypermethylated in human lung cancer by the arbitrarily primed-PCR method

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2899%2970121-2

Altered imprinting in lung cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2899%2970121-2

Prognostic significance of tumoral angiogenesis in completely resected late stage lung carcinoma (stage IIIA-N2). Impact of adjuvant therapies in a subset of patients at high risk of recurrence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2899%2970121-2

Angiogenesis as a Prognostic Indicator of Survival in Non-Small-Cell Lung Carcinoma: a Prospective Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2899%2970121-2

Immunocytochemical markers in stage I lung cancer: relevance to prognosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2899%2970121-2

Relationship between vascularity, age and survival in non-small-cell lung cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2899%2970121-2

Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2899%2970121-2

Association of vascular endothelial growth factor expression with intratumoral microvessel density and tumour cell proliferation in human epidermoid lung carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2899%2970121-2

Neoangiogenesis and p53 protein in lung cancer: their prognostic role and their relation with vascular endothelial growth factor (VEGF) expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2899%2970121-2

Vascular endothelial growth factor and nitric oxide synthase expression in human lung cancer and the relation to p53.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2899%2970121-2

Vascular endothelial growth factor and lymph node metastasis in primary lung cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2899%2970121-2

Prognostic value of vascular endothelial growth factor and its receptor Flt-1 in squamous cell lung cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2899%2970121-2

Immunohistochemical detection of basic fibroblast growth factor as a prognostic indicator in pulmonary adenocarcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2899%2970121-2

Prognostic value of basic fibroblast growth factor and its receptor (FGFR-1) in patients with non-small cell lung carcinomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2899%2970121-2

Platelet-derived endothelial cell growth factor expression correlates with tumour angiogenesis and prognosis in non-small-cell lung cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2899%2970121-2

Epithelial-neutrophil activating peptide (ENA-78) is an important angiogenic factor in non-small cell lung cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2899%2970121-2

Inhibition of interleukin-8 reduces tumorigenesis of human non-small cell lung cancer in SCID mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2899%2970121-2

Interferon-gamma-inducible protein 10 (IP-10) is an angiostatic factor that inhibits human non-small cell lung cancer (NSCLC) tumorigenesis and spontaneous metastases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2899%2970121-2

Reduced E-cadherin expression is associated with increased lymph node metastasis and unfavorable prognosis in non-small cell lung cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2899%2970121-2

Integrin expression in non-small cell carcinoma of the lung

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2899%2970121-2

Reduced integrin alpha3 expression as a factor of poor prognosis of patients with adenocarcinoma of the lung

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2899%2970121-2

Extracellular matrix expression in metastasizing and nonmetastasizing adenocarcinomas of the lung

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2899%2970121-2

Expression of gelatinase A, tissue inhibitor of metalloproteinases-2, matrilysin, and trypsin(ogen) in lung neoplasms: an immunohistochemical study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2899%2970121-2

Activation of the precursor of gelatinase A/72 kDa type IV collagenase/MMP-2 in lung carcinomas correlates with the expression of membrane-type matrix metalloproteinase (MT-MMP) and with lymph node metastasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2899%2970121-2

Abnormal expression of CCND1 and RB1 in resection margin epithelia of lung cancer patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2899%2970121-2

A follow-up study of progression from dysplasia to squamous cell carcinoma with immunohistochemical examination of p53 protein overexpression in the bronchi of ex-chromate workers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2899%2970121-2

Allele-specific chromosome 3p deletions occur at an early stage in the pathogenesis of lung carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2899%2970121-2

Allele-specific loss in chromosome 9p loci in preneoplastic lesions accompanying non-small-cell lung cancers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2899%2970121-2

Sequential molecular abnormalities are involved in the multistage development of squamous cell lung carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2899%2970121-2

Clonal genetic alterations in the lungs of current and former smokers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2899%2970121-2

Molecular damage in the bronchial epithelium of current and former smokers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2899%2970121-2

Extensive areas of aneuploidy are present in the respiratory epithelium of lung cancer patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2899%2970121-2

Widely dispersed p53 mutation in respiratory epithelium. A novel mechanism for field carcinogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2899%2970121-2

The molecular epidemiology of lung cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2899%2970121-2

Familial aggregation of lung cancer among hospital patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2899%2970121-2

Metabolic polymorphisms in carcinogen metabolising enzymes and cancer susceptibility

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2899%2970121-2

Role of glutathione S-transferase GSTM1, GSTM3, GSTP1 and GSTT1 genotypes in modulating susceptibility to smoking-related lung cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2899%2970121-2

Mass screening for lung cancer with mobile spiral computed tomography scanner

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2899%2970121-2

Early Lung Cancer Action Project: overall design and findings from baseline screening

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2899%2970121-2

Molecular Detection of Tumor Cells in Bronchoalveolar Lavage Fluid From Patients With Early Stage Lung Cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2899%2970121-2

Overexpression of Glut1 and Glut3 in stage I nonsmall cell lung carcinoma is associated with poor survival

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2899%2970121-2

Bombesin receptor structure and expression in human lung carcinoma cell lines.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2899%2970121-2

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0022-5223(99)70121-2

1 reference

29 July 2017

1 reference